Literature DB >> 22440256

Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.

Meimei Wan1, Weiwei Huang, Timothy E Kute, Lance D Miller, Qiang Zhang, Heather Hatcher, Jingxuan Wang, Daniel B Stovall, Gregory B Russell, Paul D Cao, Zhiyong Deng, Wei Wang, Qingyuan Zhang, Ming Lei, Suzy V Torti, Steven A Akman, Guangchao Sui.   

Abstract

Yin Yang 1 (YY1) is highly expressed in various types of cancers and regulates tumorigenesis through multiple pathways. In the present study, we evaluated YY1 expression levels in breast cancer cell lines, a breast cancer TMA, and two gene arrays. We observed that, compared with normal samples, YY1 is generally overexpressed in breast cancer cells and tissues. In functional studies, depletion of YY1 inhibited the clonogenicity, migration, invasion, and tumor formation of breast cancer cells, but did not affect the clonogenicity of nontumorigenic cells. Conversely, ectopically expressed YY1 enhanced the migration and invasion of nontumorigenic MCF-10A breast cells. In both a monolayer culture condition and a three-dimensional Matrigel system, silenced YY1 expression changed the architecture of breast cancer MCF-7 cells to that resembling MCF-10A cells, whereas ectopically expressed YY1 in MCF-10A cells had the opposite effect. Furthermore, we detected an inverse correlation between YY1 and p27 expression in both breast cancer cells and xenograft tumors with manipulated YY1 expression. Counteracting the changes in p27 expression attenuated the effects of YY1 alterations on these cells. In addition, YY1 promoted p27 ubiquitination and physically interacted with p27. In conclusion, our data suggest that YY1 is an oncogene and identify p27 as a new target of YY1.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440256      PMCID: PMC3828504          DOI: 10.1016/j.ajpath.2012.01.037

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  70 in total

1.  p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.

Authors:  Isabel Chu; Jun Sun; Angel Arnaout; Harriette Kahn; Wedad Hanna; Steven Narod; Ping Sun; Cheng-Keat Tan; Ludger Hengst; Joyce Slingerland
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

Review 2.  Post-translational regulation of the tumor suppressor p27(KIP1).

Authors:  J Vervoorts; B Lüscher
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

Review 3.  Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.

Authors:  S Gordon; G Akopyan; H Garban; B Bonavida
Journal:  Oncogene       Date:  2006-02-23       Impact factor: 9.867

4.  Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer.

Authors:  Bodiford Lee Stackhouse; Holly Williams; Paul Berry; Greg Russell; Pamela Thompson; Jerald L Winter; Timothy Kute
Journal:  Breast Cancer Res Treat       Date:  2005-10       Impact factor: 4.872

5.  Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior.

Authors:  Manjari Dimri; Mayumi Naramura; Lei Duan; Jing Chen; Cesar Ortega-Cava; Gengsheng Chen; Rasna Goswami; Norvin Fernandes; Qingshen Gao; Goberdhan P Dimri; Vimla Band; Hamid Band
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

6.  p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc.

Authors:  N Sankar; S Baluchamy; R-K Kadeppagari; G Singhal; S Weitzman; B Thimmapaya
Journal:  Oncogene       Date:  2008-06-09       Impact factor: 9.867

Review 7.  The involvement of the transcription factor Yin Yang 1 in cancer development and progression.

Authors:  Giancarlo Castellano; Elena Torrisi; Giovanni Ligresti; Grazia Malaponte; Loredana Militello; Alessia E Russo; James A McCubrey; Silvana Canevari; Massimo Libra
Journal:  Cell Cycle       Date:  2009-05-26       Impact factor: 4.534

8.  Yin Yang 1 regulates the transcriptional activity of androgen receptor.

Authors:  Z Deng; M Wan; P Cao; A Rao; S D Cramer; G Sui
Journal:  Oncogene       Date:  2009-08-10       Impact factor: 9.867

9.  Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

Authors:  Stefano Calza; Per Hall; Gert Auer; Judith Bjöhle; Sigrid Klaar; Ulrike Kronenwett; Edison T Liu; Lance Miller; Alexander Ploner; Johanna Smeds; Jonas Bergh; Yudi Pawitan
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

Review 10.  BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.

Authors:  Chu-Xia Deng
Journal:  Nucleic Acids Res       Date:  2006-03-06       Impact factor: 16.971

View more
  42 in total

1.  The regulation of SOX7 and its tumor suppressive role in breast cancer.

Authors:  Daniel B Stovall; Meimei Wan; Lance D Miller; Paul Cao; Dejan Maglic; Qiang Zhang; Martha R Stampfer; Wennuan Liu; Jianfeng Xu; Guangchao Sui
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

2.  YY1 regulates skeletal muscle regeneration through controlling metabolic reprogramming of satellite cells.

Authors:  Fengyuan Chen; Jiajian Zhou; Yuying Li; Yu Zhao; Jie Yuan; Yang Cao; Lijun Wang; Zongkang Zhang; Baoting Zhang; Chi Chiu Wang; Tom H Cheung; Zhenguo Wu; Carmen Chak-Lui Wong; Hao Sun; Huating Wang
Journal:  EMBO J       Date:  2019-04-12       Impact factor: 11.598

3.  Identification of DHX36 as a tumour suppressor through modulating the activities of the stress-associated proteins and cyclin-dependent kinases in breast cancer.

Authors:  Yinduo Zeng; Tao Qin; Valentina Flamini; Cui Tan; Xinke Zhang; Yizi Cong; Emily Birkin; Wen G Jiang; Herui Yao; Yuxin Cui
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Emmanouil Kalampokas; Theodoros Kalampokas; Eleftherios Spartalis; Afrodite Daskalopoulou; Serena Valsami; Michael Kontos; Afroditi Nonni; Konstantinos Kontzoglou; Despina Perrea; Nikolaos Nikiteas; Dimitrios Dimitroulis
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

Review 5.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

6.  DNA vector-based RNA interference to study gene function in cancer.

Authors:  Daniel B Stovall; Meimei Wan; Qiang Zhang; Purnima Dubey; Guangchao Sui
Journal:  J Vis Exp       Date:  2012-06-04       Impact factor: 1.355

7.  Expression of YY1 in Differentiated Thyroid Cancer.

Authors:  Jéssica Arribas; Josep Castellví; Ricard Marcos; Carles Zafón; Antonia Velázquez
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

8.  Overexpression of CD36 in mammary fibroblasts suppresses colony growth in breast cancer cell lines.

Authors:  Qingsu Cheng; Kosar Jabbari; Garrett Winkelmaier; Cody Andersen; Paul Yaswen; Mina Khoshdeli; Bahram Parvin
Journal:  Biochem Biophys Res Commun       Date:  2020-03-16       Impact factor: 3.575

Review 9.  Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

Authors:  Nicholas R Galloway; Kathryn F Ball; TessaRae Stiff; Nathan R Wall
Journal:  Crit Rev Oncog       Date:  2017

10.  Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation.

Authors:  Qiang Zhang; Meimei Wan; Jinming Shi; David A Horita; Lance D Miller; Timothy E Kute; Steven J Kridel; George Kulik; Guangchao Sui
Journal:  J Mol Cell Biol       Date:  2016-01-13       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.